Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-46,922
Closed -$4.83M 678
2023
Q3
$4.83M Buy
+46,922
New +$5.06M 0.58% 16
2022
Q3
Sell
-65,045
Closed -$5.93M 668
2022
Q2
$5.93M Buy
+65,045
New +$5.77M 0.58% 8
2022
Q1
Sell
-64,942
Closed -$4.98M 757
2021
Q4
$4.98M Buy
+64,942
New +$5.17M 0.54% 33
2021
Q2
Sell
-24,666
Closed -$1.81M 666
2021
Q1
$1.81M Buy
+24,666
New +$1.82M 0.16% 238
2020
Q4
Sell
-36,324
Closed -$2.88M 662
2020
Q3
$2.88M Sell
36,324
-22,056
-38% -$1.73M 0.18% 148
2020
Q2
$4.31M Buy
+58,380
New +$4.39M 0.39% 61
2019
Q1
Sell
-59,254
Closed -$4.32M 253
2018
Q4
$4.32M Buy
+59,254
New +$4.18M 0.25% 100

Other funds holding MRK

Duality Advisers's MRK Position: Q4 2023 in Review

Duality Advisers sold out of Merck (MRK) in Q4 2023, closing a stake of 46,922 shares — an estimated $4.83M sold.

Duality Advisers first reported a position in MRK in Q4 2018 and held it in 7 quarters. The position peaked at $5.93M in Q2 2022. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Duality Advisers reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Duality Advisers sold 46,922 Merck shares in Q4 2023, an estimated $4.83M.
  • Duality Advisers first reported a position in Merck in Q4 2018 and held it in 7 quarters.
  • Duality Advisers's Merck position peaked at $5.93M in Q2 2022.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.